OLEMA PHARMACEUTICALS INC's ticker is OLMA and the CUSIP is 68062P106. A total of 78 filers reported holding OLEMA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $480 | -12.7% | 38,846 | -36.2% | 0.00% | – |
| Q2 2023 | $550 | +170.9% | 60,853 | +4.4% | 0.00% | – |
| Q1 2023 | $203 | +20.8% | 58,300 | -14.9% | 0.00% | – |
| Q4 2022 | $168 | -99.9% | 68,500 | 0.0% | 0.00% | – |
| Q3 2022 | $190,000 | -31.9% | 68,500 | 0.0% | 0.00% | – |
| Q2 2022 | $279,000 | -7.6% | 68,500 | -3.3% | 0.00% | – |
| Q1 2022 | $302,000 | -54.0% | 70,872 | +1.0% | 0.00% | – |
| Q4 2021 | $657,000 | +172.6% | 70,172 | +713.8% | 0.00% | – |
| Q2 2021 | $241,000 | -13.9% | 8,623 | +2.0% | 0.00% | – |
| Q1 2021 | $280,000 | – | 8,450 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paradigm Biocapital Advisors LP | 7,803,600 | $96,374,460 | 6.54% |
| Logos Global Management LP | 3,743,875 | $46,236,856 | 6.17% |
| MPM BioImpact LLC | 1,857,681 | $22,942,360 | 6.12% |
| Cormorant Asset Management, LP | 4,504,764 | $55,633,835 | 3.24% |
| BVF INC/IL | 9,135,893 | $112,828,279 | 3.04% |
| Vivo Capital, LLC | 1,873,704 | $23,140,244 | 2.54% |
| Altium Capital Management LP | 335,000 | $4,137,250 | 2.16% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 407,801 | $5,036,342 | 1.53% |
| HighVista Strategies LLC | 247,880 | $3,061,318 | 1.42% |
| ACUTA CAPITAL PARTNERS, LLC | 153,007 | $1,889,636 | 1.27% |